Fresenius Medical Care Of Fairfield is a medicare approved dialysis facility center in Fairfield, Connecticut and it has 18 dialysis stations. It is located in Fairfield county at 500 Kings Hwy, Fairfield, CT, 06825. You can reach out to the office of Fresenius Medical Care Of Fairfield at (203) 583-8875. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Of Fairfield has the following ownership type - Profit. It was first certified by medicare in November, 2008. The medicare id for this facility is 072536 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Of Fairfield |
|---|---|
| Location | 500 Kings Hwy, Fairfield, Connecticut |
| No. of Dialysis Stations | 18 |
| Medicare ID | 072536 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 500 Kings Hwy, Fairfield, Connecticut, 06825 | |
| (203) 583-8875 | |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
| NPI Number | 1073796421 |
| Doing Business As | Liberty Dialysis - Fairfield Llc |
| Address | 500 Kings Hwy Fairfield, Connecticut, 06825 |
| Phone Number | (206) 236-5001 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 34 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 32 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 48 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 454 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
| Adult patients getting regular peritoneal dialysis at the center | 7 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 48 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Of Fairfield with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 522 |
| Patients with Serumphosphor | 57 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 60 |
| Patient months included in arterial venous fistula and catheter summaries | 425 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 45 |
| Hospitalization Rate in facility | 234.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 393.1 |
| Hospitalization Rate: Lower Confidence Limit | 145 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Of Fairfield were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 44.2 (Worse than Expected) |
| Readmission Rate: Upper Confidence Limit | 57.6 |
| Readmission Rate: Lower Confidence Limit | 31.4 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Of Fairfield get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.29 (As Expected) |
| SIR: Upper Confidence Limit | 3.11 |
| SIR: Lower Confidence Limit | .41 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Of Fairfield's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 37 |
| Transfusion Rate in facility | 44.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 128.5 |
| Transfusion Rate: Lower Confidence Limit | 17.4 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Of Fairfield lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 177 |
| Mortality Rate in facility | 15.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24.4 |
| Mortality Rate: Lower Confidence Limit | 8.9 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago
Fresenius Medical Care Of Fairfield Location: 500 Kings Hwy, Fairfield, Connecticut, 06825 Phone: (203) 583-8875 |
News Archive
A new campaign has been launched in the UK highlighting the often ignored issue of self harm.
Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System (GPS) featuring Surgeon's Checklist software, through DePuy Synthes Companies' sales representatives worldwide.
IRIN reports on women's efforts to curb population growth in Madagascar, "one of 12 developing countries receiving support to improve access to contraceptives through the U.N. Population Fund's (UNFPA) Global Programme to Enhance Reproductive Health Commodity Security."
Accelr8 Technology Corporation today announced that it completed the sale of a non-exclusive license for its proprietary OptiChem bio-coatings to an innovative, public diagnostics company. The licensee is paying $1,865,000 over four annual escalating payments and intends to use OptiChem® in its disposable diagnostic devices.
Theresa Oles runs for her life every day. This fall, the nurse anesthesist who goes running to unwind, is pounding the pavement to fight breast cancer in the Chicago Breast Cancer Network of Strength marathon.
› Verified 3 days ago